Bartlett EE, Grayson M, Barker R, et al. 1984. The effects of physician communications skills on patient satisfaction, recall, and adherence. Journal of Chronic Diseases 37(9-10):755-764.
Beam CA, Layde PM, Sullivan DC. 1996. Variability in the interpretation of screening mammograms by U.S. radiologists. Findings from a national sample. Archives of Internal Medicine 156(2):209-213.
Bonadonna G, Valagussa P. 1985. Adjuvant systemic therapy for resectable breast cancer. Journal of Clinical Oncology 3(2): 259-275.
Bostwick DG, Myers RP, Oesterling JE. 1994. Staging of prostate cancer. Seminars in Surgical Oncology 10:60-72.
Brook R, Chassin M, Fink A. 1986. A method for detailed assessment of the appropriateness of medical technologies. International Journal of Technology Assessment in Health Care 2:53-63.
Brook R, Park R, Chassin M, et al. 1990. Carotid endarterectomy for elderly patients: Predicting complications. Annals of Internal Medicine 113:747-753.
Centers for Disease Control and Prevention. 1998. The National Program of Cancer Registries AT-A-GLANCE 1998. http://www.cdc.gov/nccdphp/dcpc/npcr/register.htm.
Cleary P, McNeil B. 1988. Patient satisfaction as an indicator of quality care. Inquiry 25:25-36.
Cole P, Rodu B. 1996. Declining cancer mortality in the United States. Cancer 78:2045-2048.
Correa RJ. 1998. American Urological Association response to AHCPR notice of assessment of PSA test. American Urological Association. Baltimore, MD.
Davies A, Ware J. 1988. Involving consumers in quality of care assessment. Health Affairs 7:33-48.
Deyo R, Inui T. 1980. Dropouts and broken appointments: A literature review and agenda for future research. Medical Care 18:1146-1157.
Donabedian A. 1980. Explorations in Quality Assessment and Monitoring , Volume I: The Definition of Quality and Approaches to Its Assessment . Ann Arbor, MI: Health Administration Press.
Early Breast Cancer Trialists' Collaborative Group. 1992. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 399:1-71.
Early Breast Cancer Trialists' Collaborative Group. 1998. Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467.
Eastman P. 1997. NCI adopts new mammography screening guidelines for women. Journal of the National Cancer Institute 89:538-539.
Farrow DC, Hunt WC, Samet JM. 1992. Geographic variation in the treatment of localized breast cancer. New England Journal of Medicine 326:1097-1101.
Farrow DC, Samet JM, and Hunt WC. 1996. Regional variation in survival following the diagnosis of cancer. Journal of Clinical Epidemiology 49(8)843-847.
Fisher B, Bauer M, Margolese R, et al. 1985. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New England Journal of Medicine 312:665-673.
Fisher B, Dignam J, Wolmark N, et al. 1997. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. Journal of the National Cancer Institute 89:1673-1682.
Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ. 1992a. Breast conservation versus mastectomy: Is there a difference in psychological adjustment of quality of life in the year after surgery? Cancer 69:1729-1738.
Ganz PA, Schag CA, Lee JJ, Sim MS. 1992b. The CARES: A generic measure of health-related quality of life for patients with cancer. Quality of Life Research 1:19-29.
Garnick MB. 1996. Prostate cancer: Screening, diagnosis, and management. Annals of Internal Medicine 118(10):804-818.
GIVIO. 1994. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. Journal of the American Medical Association 271 (20):1587-1592.